Is atopy a risk indicator of chronic obstructive pulmonary disease in dairy farmers?

Respir Res. 2019 Jun 17;20(1):124. doi: 10.1186/s12931-019-1082-2.

Abstract

Allergic mechanisms related to environmental and occupational exposure have been suggested to contribute to the development of chronic obstructive pulmonary disease (COPD).

Objectives: To investigate the relationships between atopy markers, persistent airflow limitation (PAL) and occupational exposure in dairy farmers.

Methods: Clinical and biological (total IgE and 21 allergen specific IgE) markers of atopy were assessed in 101 dairy farmers with PAL (DF-PAL), 85 non-farmers with PAL (NF-PAL) (both groups were prospectively included from a screening program performed between 2011 and 2015), and matched controls, i.e. 98 farmers without PAL (DF-controls) and 89 non-farming subjects without PAL (NF-controls). Occupational exposure in farmers was estimated using a validated questionnaire.

Results: Prevalence of allergy history was significantly higher in DF-PAL and in NF-PAL than in controls. Polysensitization, and sensitization to seasonal and food allergens were more frequent in DF-PAL than in DF-controls, respectively: 13.8% vs 1% (adjusted odds ratio (aOR): 17.5 (2.2-134), 11.9% vs 3.1% (aOR: 4.4 (1.2-7.2) and 16.8% vs 4.1% (aOR: 5.2 (1.7-7.2)). The prevalence of atopy markers was similar between NF-PAL patients and NF-controls.

Conclusions: PAL in farmers is associated with a high rate of markers of atopy, supporting atopy as a risk indicator. Clinical trial registered with ClinicalTrials.gov (NCT02540408).

Keywords: Atopy; Chronic obstructive pulmonary disease; Farmers; Matthieu Veil-Picard and Thibaud Soumagne contributed equally to the work.; Occupational exposure; Specific IgE.

Publication types

  • Clinical Trial

MeSH terms

  • Aged
  • Agricultural Workers' Diseases / diagnosis
  • Agricultural Workers' Diseases / epidemiology*
  • Agricultural Workers' Diseases / immunology
  • Dairying*
  • Farmers*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Occupational Exposure / adverse effects*
  • Pulmonary Disease, Chronic Obstructive / diagnosis
  • Pulmonary Disease, Chronic Obstructive / epidemiology*
  • Pulmonary Disease, Chronic Obstructive / immunology
  • Risk Factors

Associated data

  • ClinicalTrials.gov/NCT02540408